Navigation Links
deCODE genetics Announces First Quarter 2008 Financial Results
Date:5/1/2008

REYKJAVIK, Iceland, May 1 /PRNewswire-FirstCall/ -- deCODE genetics (Nasdaq: DCGN) today announced its consolidated financial results for the quarter ended March 31, 2008. A conference call to discuss the quarter's results and recent operating highlights will be webcast live tomorrow, Friday, May 2, at 8:00am Eastern Time/12 noon GMT/1pm British Summer Time (details below).

Net loss for the quarter ending March 31, 2008 was $26.7 million, compared to $22.6 million for the first quarter 2007. Basic and diluted net loss per share was $0.44 for the first quarter 2008, versus $0.37 for the same quarter last year. At the close of the first quarter 2008, the company had approximately 61.8 million shares outstanding.

Revenue for the first quarter of this year increased to $15.0 million from $8.6 million for the first quarter 2007. The most significant factor in this increase in revenue is the continued growth in the company's genomic services business. At March 31, 2008, the company had $16.2 million in deferred revenue that will be recognized over future reporting periods.

Research and development expense was $12.7 million for the first quarter of this year, compared to $12.7 million for the same period last year. Our research and development expense in the past quarter includes costs related to the development and launch of our latest DNA-based tests for gauging individual risk of a growing number of common diseases and ongoing gene discovery work that is feeding our diagnostics pipeline and deCODEme service.

Selling, general and administrative expense for the first quarter of 2008 was $7.2 million, compared to $5.5 million for the 2007 period. The year-on- year increase in SG&A expense reflects in part the launch a
'/>"/>

SOURCE deCODE genetics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. deCODE Discovers Fourth Major Set of Common Genetic Variants Linked to Risk of Estrogen Receptor-Positive Breast Cancer
2. deCODE Lauds Federal Legislation to Ban Discrimination on the Basis of Genetic Information
3. deCODE genetics Announces Webcast of Conference Call to Discuss First Quarter 2008 Financial Results
4. U.S. Preventive Medicine and deCODE Genetics Sign Letter of Intent to Expand Personalized Medicine Platform
5. A Smoking Gene: deCODE Shows How a Single Variant in the Sequence of the Genome Confers Nicotine Dependence and Risk of Lung Cancer and Other Disease
6. deCODE genetics to Webcast Presentation at 15th Annual Future Leaders in the Biotech Industry Conference
7. deCODE genetics to Webcast Presentation at Lehman Brothers Eleventh Annual Global Healthcare Conference
8. deCODE Genetics Announces Full-year 2007 Financial Results
9. deCODE genetics Announces Webcast of Conference Call to Discuss Full-year 2007 Financial Results
10. deCODE genetics to Webcast Presentation at BIO CEO and Investor Conference
11. deCODE Discovers Gene Variants that May Help to Distribute the Work of Evolution between Men and Women

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... A mechanised blue dye test alternative...g quality assurance one step closer for pharma-com... testing machine developed by Sepha for use wit...in several local and global pharma-companies such ...ity assurance and productivity improvements on the...
(Date:11/25/2009)..., DURHAM, N.C., Nov. 25 Research ... energy-efficient, single-treatment water purifica...otubes to Andhra Pradesh, Minister of Rural Water ...n Hyderabad, India today. Initial tests, performed...onfirmed that the majority of the drinking water a...
(Date:11/25/2009)... Ambassador to Speak at Economic Club of... (Vocus) November 25, 2009 -- Ambassador to Speak ...ppia, French Ambassador for International Investme...gency ,To view a biography of David Appia go to w...pia is available to meet with press to discuss rec...
(Date:11/25/2009)...KHAM, ON, Nov. 25 /PRNewswire/ - Cytochroma today ...ts Board of Directors. Dr. Moldt will replace Mr. ...Company,s Board. The number of Board members remai...eased to welcome Peter Moldt to the board and look...dance as Cytochroma continues to make progress in ...
Breaking Biology Technology:Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 2Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 3North Carolina-based Cnanoz Unveils NanoPure(TM) to Government Leaders in Hyderabad, India 2French Ambassador for International Investment to Visit Toronto December 11 2Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2
...hows naturally occurring antibodies contained in, ...for Alzheimer,s disease, CHICAGO, April 15 The U...axter International Inc. (NYSE: BAX ) today,annou...tural antibodies,contained in GAMMAGARD LIQUID [Im... as KIOVIG in the European Union, a plasma-derived...
.../PRNewswire-FirstCall/ - Oncolytics Biotech Inc.,(...sentation by Dr.,Chandini Thirukkumaran of the Tom... Multiple Myeloma with Oncolytic Viral Therapy" wa...Cancer Research (AACR) Annual,Meeting. The meeting...,12-16, 2008., The presentation covered preclinic...
... CryoPort, Inc. (OTC,Bulletin Board: CYRX) (http...ent,community through their personal profile on My...he dynamic profile will include interviews with co...ent, and links to recent press., Visit CryoPort,.../profile.php?ID=19849 . Stay updated about CryoPo...
Other Biology Technology:Study Suggests GAMMAGARD LIQUID May Target the Primary Pathway Involved in Alzheimer's Disease 2Study Suggests GAMMAGARD LIQUID May Target the Primary Pathway Involved in Alzheimer's Disease 3Study Suggests GAMMAGARD LIQUID May Target the Primary Pathway Involved in Alzheimer's Disease 4Study Suggests GAMMAGARD LIQUID May Target the Primary Pathway Involved in Alzheimer's Disease 5Oncolytics Biotech Inc. Collaborators Present Reovirus Research for Multiple Myeloma at AACR Annual Meeting 2CryoPort Creates Personal Wall on Wallst.net's Financial Social Community, my.wallst.net 2
(Date:11/30/2009)...ght the stress of seeing your extended family over...w research report in the December 2009 print issue...w.jleukbio.org ) shows that you might be right. He...ght lead to entirely new treatments that help keep...zema under control. That,s because researchers fro...
(Date:11/30/2009)...orless and odorless radioactive gas that is produc... product of uranium decay and is found in trace am...oundwater as well as building materials, plants, a...on is expressed as the amount of radiation that wo...a liter of air; thus the units are picocuries per ...
(Date:11/26/2009)...at last worked out a way of using recordings of bi...lations. This is the first time sound recordings f...ccurate estimates of bird species, populations. Be...cological Society,s Journal of Applied Ecology , ... major advance in our ability to monitor whale and...
Breaking Biology News(10 mins):Seeing family for the holidays? Scientists discover how the stress might kill you 2Health Physics Society recommends considering action for indoor radon below current guidelines 2Ecologists sound out new solution for monitoring cryptic species 2Video 3A Phase III Head to Head Trial Showed Ticagrelor Reduced Cardiovascular Death and Heart Attacks Over Clopidogrel in Acute Coronary Syndromes Pa 55651 1Video 3A Phase III Head to Head Trial Showed Ticagrelor Reduced Cardiovascular Death and Heart Attacks Over Clopidogrel in Acute Coronary Syndromes Pa 55651 2Video 3A Phase III Head to Head Trial Showed Ticagrelor Reduced Cardiovascular Death and Heart Attacks Over Clopidogrel in Acute Coronary Syndromes Pa 55651 3Video 3A Phase III Head to Head Trial Showed Ticagrelor Reduced Cardiovascular Death and Heart Attacks Over Clopidogrel in Acute Coronary Syndromes Pa 55651 4Video 3A Phase III Head to Head Trial Showed Ticagrelor Reduced Cardiovascular Death and Heart Attacks Over Clopidogrel in Acute Coronary Syndromes Pa 55651 5Video 3A Phase III Head to Head Trial Showed Ticagrelor Reduced Cardiovascular Death and Heart Attacks Over Clopidogrel in Acute Coronary Syndromes Pa 55651 6Alcohol Ads on Cable TV Reach Young Audiences 55648 1Alcohol Ads on Cable TV Reach Young Audiences 55648 2Alcohol Ads on Cable TV Reach Young Audiences 55648 3ColorAlchemy is Featured on HeartandHome Radio Show and Shares the Secret Color for Instant Calm and Clarity 55644 1ColorAlchemy is Featured on HeartandHome Radio Show and Shares the Secret Color for Instant Calm and Clarity 55644 2ColorAlchemy is Featured on HeartandHome Radio Show and Shares the Secret Color for Instant Calm and Clarity 55644 3ColorAlchemy is Featured on HeartandHome Radio Show and Shares the Secret Color for Instant Calm and Clarity 55644 4
...unces the launch of SAFmodule(TM) 3.1 SP3 to expan...biometric authentication methods, AUSTIN, Texas, ...sily managed biometric authentication to Novell(R)...n security framework with Novell,s,Novell Modular ...rk. NMAS,is a component of eDirectory, Novell,s ma...
...ional team of researchers led by the Smithsonian I...siensis, commonly referred to as the hobbit, a 3-f...ered four years ago on the Indonesian island of Fl...onfirmations of the original interpretation of the...human migrations to Asia. The research is being pu...
...Ill. In the battle against bacteria, researchers ...ry that could shorten the road to new and more pot...al resistance to conventional antibiotics (such as...ic health concern. Because resistant strains of ba...eate antibiotics, understanding how these molecule...
Other Biology News:IdentiPHI Re Launches SAFmodule Software to Secure Novell(R) Networks 2New research sheds light on 'Hobbit' 2Scientists decipher mechanism behind antimicrobial 'hole punchers' 2
BD Phosflow Fix Buffer I from BD Biosciences Pharmingen
Anti-Ku (p70 / p80) Ab-3 Monoclonal Antibody, Unconjugated from Lab Vision
Rabbit Anti-Rat 5-HIAA Polyclonal Antibody, Unconjugated from ImmunoStar, Inc.
NuCycl DAPI Kit from Exalpha Biologicals, Inc.
Biology Products: